TP53 and head and neck squamous cell carcinoma: Mutations of the TP53 tumor suppressor gene are the most frequent of all somatic genomic alterations in head and neck squamous cell carcinomas (HNSCCs), with a mutation frequency in non-human papilloma virus-associated HNSCC cases ranging from 75 to 85% [1–3].